Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor, Adult × leronlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1 Colorectal Neoplasms 1

Interventions

tislelizumab 1 pembrolizumab 1 patritumab deruxtecan 1 leronlimab 1 lenvatinib 1 atezolizumab 1 Tiragolumab 1 Radiotherapy 1 Cryosurgery 1 3-amino-1-methyl-3-(4-(3-phenyl-5H- imidazo(1,2-c)pyrido(3,4-e)(1,3)oxazin-2-yl)phenyl)cyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

CytoDyn, Inc.

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡